Results 1 to 10 of about 1,412,546 (392)
BMC Genomic Data, 2022 Background The incidence of pulmonary embolism complications in the literature ranges from 10 to 50%, with a 0.5–10% risk of fatal pulmonary embolism. However, the biological cause of pulmonary embolism is unknown.
Ruoyang Feng +7 more
doaj +2 more sources
Pulmonary vasodilation in acute pulmonary embolism – a systematic review
Pulmonary Circulation, 2020 Acute pulmonary embolism is the third most common cause of cardiovascular death. Pulmonary embolism increases right ventricular afterload, which causes right ventricular failure, circulatory collapse and death.
Mads Dam Lyhne +3 more
doaj +2 more sources
The dual role of Iliac vein compression in the occurrence of pulmonary embolism [PDF]
Thrombosis JournalObjective This study explores the risk factors for pulmonary embolism in patients with acute left lower extremity deep vein thrombosis and investigates the dual role of left iliac vein compression in the occurrence of pulmonary embolism.
Dafang Liu +4 more
doaj +2 more sources
Postpartum pulmonary cryptococcosis combined with pulmonary embolism: a case report [PDF]
BMC Pulmonary MedicinePulmonary cryptococcosis is an opportunistic infection of the lungs caused by cryptococcus, usually occurring in immunosuppressed patients. Pulmonary embolism is a type of venous thromboembolism.
Yapei Cui +6 more
doaj +2 more sources
British medical journal, 2022 Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19. Design Self-controlled case series and matched cohort study. Setting National registries in Sweden. Participants 1 057 174 people who tested positive
I. Katsoularis +7 more
semanticscholar +1 more source
Pulmonary Embolism in Patients with COVID-19
Clinical Cardiology and Cardiovascular Interventions, 2022 Infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and the resulting syndrome, COVID-19, have been associated with inflammation and a prothrombotic state, with increases in fibrin, fibrinogen, fibrin degradation ...
Scarduelli Cleante +2 more
semanticscholar +1 more source
Interventional therapies for pulmonary embolism
Nature Reviews Cardiology, 2023 Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most frequent cause of cardiovascular death. The clinical presentation of PE is variable, and choosing the appropriate treatment for individual patients can be challenging ...
Felix Götzinger +9 more
semanticscholar +1 more source
Diagnosis and treatment of acute pulmonary embolism: A single center experience
Acta Medica Alanya, 2022 Aim: Pulmonary embolism is a potentially life-threatening cardiovascular disease frequently encountered in emergency departments. The computed tomography pulmonary angiography is the imaging modality of choice in the diagnosis of pulmonary embolism. This
Ramazan Sami Aktaş +4 more
doaj +1 more source
Respiratory Research, 2023 Objectives To investigate whether COVID-19 patients with pulmonary embolism had higher mortality and assess the utility of d-dimer in predicting acute pulmonary embolism. Patients and methods Using the National Collaborative COVID-19 retrospective cohort,
Muhammad H. Gul +9 more
doaj +1 more source
Diagnostics, 2023 Patients with chronic cardiopulmonary pathologies have an increased risk of developing venous thromboembolic events. The worsening of dyspnoea is a frequent occurrence and often leads patients to consult the emergency department.
Delphine Douillet +3 more
doaj +1 more source